Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sign up

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      Get started

      25 trials found for Breast cancer, Breast Neoplasm

      All(25)
      Recruiting(22)
      Not yet recruiting(3)
      Recruiting
      NCT05194072
      A Study of SGN-B7H4V in Advanced Solid Tumors

      Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms, Triple Negative Breast Neoplasms, HER2 Negative Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung,

      Male or Female
      18+ years
      18study location(s)
      Recruiting
      NCT05909397
      A Study of ARV-471 (PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer

      Breast Cancer

      Male or Female
      18+ years
      62study location(s)
      Recruiting
      NCT06125522
      TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

      Breast Cancer

      Male or Female
      18+ years
      40study location(s)
      Recruiting
      NCT06105632
      A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

      Advanced or Metastatic Breast Cancer

      Male or Female
      18+ years
      64study location(s)
      Recruiting
      NCT04606446
      Study of PF-07248144 in Advanced or Metastatic Solid Tumors

      Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

      Male or Female
      18+ years
      106study location(s)
      Recruiting
      NCT05208762
      A Study of SGN-PDL1V in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

      Male or Female
      18+ years
      23study location(s)
      Recruiting
      NCT06161181
      Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients

      Metastatic Breast Cancer

      Females
      18+ years
      1study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      16study location(s)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      159study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      13study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(25)
      Recruiting(22)
      Not yet recruiting(3)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.